9 drug firms to be fined Rs 2500 cr for overpricing: Report
Friday, July 19th, 2013New Delhi: Soon, many big names in the pharma industry will have to bite a bitter pill of Rs 2500 crore as penalty for drugs overpricing. According to reports, the National Pharmaceutical Pricing Authority (NPPA) has penalised nine companies including Ranbaxy, Dr Reddy’s Labs, Glenmark, Cipla and Cadila Health, for allegedly selling anti-asthma drug Doxofylline […]
